Moreover, mutation patterns are likely to vary highly across cell lines as DNA repair genes are among the most frequently disrupted in cancer (e.g. TP53), and may be especially difficult to predict in the absence of DNA repair deficiencies as relatively normal cells exhibit erratic CRISPR editing (35). The gene discussed is TP53; the disease is cancer.